-
WHY PATIENTS NEED YOU Pfizer's purpose is to deliver breakthroughs that change patients' lives. Research and Development is at the heart of fulfilling Pfizer's purpose as we work to translate advanced science and technologies into the therapies and vaccines that matter most. Whether you are in...
-
academic organizations, institutes, and other biopharmaceutical organizations. QUALIFICATIONS PhD with 15+ years of experience in biotechnology and/or postdoctoral research focused on discovery and drug
-
to achieve meaningful outcomes and create business impact. Advanced scientific/healthcare degree required (PharmD, PhD, MS, etc.) Minimum 6 years experience in the healthcare/pharmaceutical sector with 3
-
+ years of experience . MS, PharmD, PhD or MD preferred. Equivalent workplace experience can be considered. Extensive direct regulatory experience, preferably including as a Global Regulatory Lead and
-
degree, preferably in a life science discipline. BS/BA +5 years, MS/MA +3 years, PhD +0 year s of experience in medical writing or related field. Understanding of the role of each member of cross
-
years or equivalent PhD/PharmD/MD - 9 years or equivalent Extensive knowledge of ICH GCP and regulations in order to assess GCP situations and coordinate resolution activities across partner lines. Expert
-
development to support launch and post-launch success. BASIC QUALIFICATIONS Clinically trained (MD, ClinPharm), PharmD, MD-PhD desired Oncology medical professional with strong experience (at least 9 years if
-
PhD in Pharmacometrics, Clinical Pharmacology, Pharmacokinetics, Engineering, Pharmaceutical Sciences, or PharmD Strong written and verbal communication skills PREFERRED QUALIFICATIONS Experience
-
compliance. Provide subject matter expertise and guidance to colleagues. Lead / co-lead complex pilot studies and projects across preclinical Pfizer Oncology enterprise. BASIC QUALIFICATIONS PhD with 4+ years
-
ROLE SUMMARY Pfizer's Oncology Research Unit (ORU) in La Jolla, California, is seeking a Senior Scientist (PhD) focused on translating basic discoveries in the field of cancer epigenetics into novel